Journal of the American Academy of Dermatology
Volume 59, Issue 3 , Pages 405-417, September 2008

Outcomes of melanoma in recipients of solid organ transplant

  • Daniel C. Dapprich, MD

      Affiliations

    • Department of Dermatology, Mayo Clinic, Rochester, Minnesota
  • ,
  • Roger H. Weenig, MD

      Affiliations

    • Department of Dermatology, Mayo Clinic, Rochester, Minnesota
  • ,
  • Audrey L. Rohlinger, BS

      Affiliations

    • Division of Biostatistics, Mayo Clinic, Rochester, Minnesota
  • ,
  • Amy L. Weaver, MS

      Affiliations

    • Division of Biostatistics, Mayo Clinic, Rochester, Minnesota
  • ,
  • Katherine K. Lim Quan, MD

      Affiliations

    • Department of Dermatology, Mayo Clinic, Rochester, Minnesota
  • ,
  • James H. Keeling, MD

      Affiliations

    • Department of Dermatology, Mayo Clinic, Jacksonville, Florida
  • ,
  • John S. Walsh, MD

      Affiliations

    • Department of Dermatology, Mayo Clinic, Jacksonville, Florida
  • ,
  • Clark C. Otley, MD

      Affiliations

    • Department of Dermatology, Mayo Clinic, Rochester, Minnesota
    • Corresponding Author InformationReprint requests: Clark C. Otley, MD, Department of Dermatology, Mayo Clinic, 200 First St SW, Rochester, MN 55905.
  • ,
  • Leslie J. Christenson, MD

      Affiliations

    • Department of Dermatology, Mayo Clinic, Rochester, Minnesota

Accepted 13 May 2008. published online 16 June 2008.

Background

There is concern that the immunologic tumor malignant melanoma (MM) may have worse outcomes in immunosuppressed hosts than in the general population.

Objective

We sought to describe outcomes of MM in immunosuppressed solid organ transplant recipients and compare them with the general population.

Methods

We conducted a retrospective review of medical charts and pathology slides of cases of MM and solid organ transplantation between 1978 and 2007, with comparison of outcomes.

Results

In all, 48 MMs were identified in 43 transplant recipients. No patient with MM before transplant receipt had melanoma recurrence, subsequent metastasis, or death caused by melanoma. Of patients with MM diagnosed after transplantation, metastases developed in 3 patients, and two patients died of melanoma.

Limitations

Retrospective review and low number of cases are limitations.

Conclusions

Outcomes of MM in immunosuppressed transplant recipients appeared similar to those in prognostically matched nonimmunosuppressed hosts. The small number of cases limited statistical comparisons.

Abbreviations used: AJCC, American Joint Committee on Cancer, MM, malignant melanoma, NMSC, nonmelanoma skin cancer

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Funding sources: None.

 Conflicts of interest: None declared.

PII: S0190-9622(08)00608-7

doi:10.1016/j.jaad.2008.05.015

Journal of the American Academy of Dermatology
Volume 59, Issue 3 , Pages 405-417, September 2008